Publication Name	World Journal of Hepatology
Manuscript ID	19149
Country	Germany

Received	2015-05-01 14:13
Peer-Review Started	2015-05-08 07:57
To Make the First Decision	2015-09-08 10:31
Return for Revision	2015-09-11 18:20
Revised	2015-10-12 22:27
Second Decision	2015-12-29 11:21
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-07 16:28
Articles in Press	2016-01-07 16:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-10 17:53
Publish the Manuscript Online	2016-01-21 09:23

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Advances in hepatitis C therapy: What is the current state - what come's next?
Manuscript Source	Invited Manuscript
All Author List	Steffen Zopf, Andreas E Kremer, Markus F Neurath and Juergen Siebler
Funding Agency and Grant Number
Corresponding Author	Steffen Zopf, MD, Medical Department 1, University of Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany. steffen.zopf@uk-erlangen.de
Key Words	hepatitis C virus; direct antiviral agents; sustained virological response; liver transplantation; renal impairment; cirrhosis
Core Tip	Treatment of chronic hepatitis C virus (HCV) infections has undergone a revolutionary change in recent years. This review highlights the current state of the art of antiviral treatment in chronic hepatitis C infections and gives an outlook for upcoming therapies. Difficult to treat populations such as patients with decompensated liver cirrhosis, HCV-human immuno-deficiency virus co-infections, after liver transplantation and patients with renal impairment or on hemodialysis are highlighted.
Publish Date	2016-01-21 09:23
Citation	Zopf S, Kremer AE, Neurath MF, Siebler J. Advances in hepatitis C therapy: What is the current state - what come’s next? World J Hepatol 2016; 8(3): 139-147
URL	http://www.wjgnet.com/1948-5182/full/v8/i3/139.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i3.139

Full Article (PDF)	WJH-8-139.pdf
Full Article (Word)	WJH-8-139.doc
Manuscript File	19149-Review.docx
Answering Reviewers	19149-Answering reviewers.pdf
Audio Core Tip	19149-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19149-Conflict-of-interest statement.pdf
Copyright License Agreement	19149-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	19149-Language certificate.pdf
Peer-review Report	19149-Peer-review(s).pdf
Scientific Misconduct Check	19149-Scientific misconduct check.pdf
Scientific Editor Work List	19149-Scientific editor work list.pdf